TY - JOUR
T1 - Rational Reprogramming of Cellular States by Combinatorial Perturbation
AU - Duan, Jialei
AU - Li, Boxun
AU - Bhakta, Minoti
AU - Xie, Shiqi
AU - Zhou, Pei
AU - Munshi, Nikhil V.
AU - Hon, Gary C.
N1 - Funding Information:
We thank all the members in Hon and Munshi laboratories for insightful discussions and Ning Liu for reviewing the manuscript. This work is supported by the Cancer Prevention Research Institute of Texas (CPRIT) (RR140023 and RP190451 to G.C.H.), NIH (DP2GM128203 to G.C.H.; HL136604, HL133642, and HL133642 to N.V.M), the Department of Defense (PR172060 to G.C.H. and N.V.M.), the Welch Foundation (I-1926-20170325 to G.C.H.), the Burroughs Wellcome Fund (1009838 to N.V.M.), the March of Dimes Foundation (5-FY13-203 to N.V.M.), and the Green Center for Reproductive Biology. G.C.H. is a CPRIT Scholar in Cancer Research. We acknowledge the BioHPC computational infrastructure at UT Southwestern for providing HPC and storage resources that have contributed to the research results reported within this paper. We acknowledge UT Southwestern's McDermott Center, Flow Cytometry Core, and the O'Brien Kidney Center: Cell Biology and Imaging Core for providing next-generation sequencing services, flow cytometry services, and confocal microscopy services for this work, respectively. Conceptualization, N.V.M. and G.C.H.; Methodology, J.D. B.L. M.B. N.V.M. and G.C.H.; Software, J.D. and B.L.; Validation, M.B. and B.L.; Formal Analysis, J.D. and B.L.; Investigation, J.D. M.B. B.L. P.Z. and S.X.; Writing – Original Draft, J.D. B.L. N.V.M. and G.C.H.; Writing – Review & Editing, J.D. B.L. N.V.M. and G.C.H.; Supervision, N.V.M. and G.C.H.; Funding Acquisition, N.V.M. and G.C.H. The authors declare no competing interests.
Funding Information:
We thank all the members in Hon and Munshi laboratories for insightful discussions and Ning Liu for reviewing the manuscript. This work is supported by the Cancer Prevention Research Institute of Texas (CPRIT) ( RR140023 and RP190451 to G.C.H.), NIH ( DP2GM128203 to G.C.H.; HL136604 , HL133642 , and HL133642 to N.V.M), the Department of Defense ( PR172060 to G.C.H. and N.V.M.), the Welch Foundation ( I-1926-20170325 to G.C.H.), the Burroughs Wellcome Fund ( 1009838 to N.V.M.), the March of Dimes Foundation ( 5-FY13-203 to N.V.M.), and the Green Center for Reproductive Biology . G.C.H. is a CPRIT Scholar in Cancer Research. We acknowledge the BioHPC computational infrastructure at UT Southwestern for providing HPC and storage resources that have contributed to the research results reported within this paper. We acknowledge UT Southwestern’s McDermott Center, Flow Cytometry Core, and the O’Brien Kidney Center: Cell Biology and Imaging Core for providing next-generation sequencing services, flow cytometry services, and confocal microscopy services for this work, respectively.
Funding Information:
We thank all the members in Hon and Munshi laboratories for insightful discussions and Ning Liu for reviewing the manuscript. This work is supported by the Cancer Prevention Research Institute of Texas (CPRIT) (RR140023 and RP190451 to G.C.H.), NIH (DP2GM128203 to G.C.H.; HL136604, HL133642, and HL133642 to N.V.M), the Department of Defense (PR172060 to G.C.H. and N.V.M.), the Welch Foundation (I-1926-20170325 to G.C.H.), the Burroughs Wellcome Fund (1009838 to N.V.M.), the March of Dimes Foundation (5-FY13-203 to N.V.M.), and the Green Center for Reproductive Biology. G.C.H. is a CPRIT Scholar in Cancer Research. We acknowledge the BioHPC computational infrastructure at UT Southwestern for providing HPC and storage resources that have contributed to the research results reported within this paper. We acknowledge UT Southwestern's McDermott Center, Flow Cytometry Core, and the O'Brien Kidney Center: Cell Biology and Imaging Core for providing next-generation sequencing services, flow cytometry services, and confocal microscopy services for this work, respectively. Conceptualization, N.V.M. and G.C.H.; Methodology, J.D. B.L. M.B. N.V.M. and G.C.H.; Software, J.D. and B.L.; Validation, M.B. and B.L.; Formal Analysis, J.D. and B.L.; Investigation, J.D. M.B. B.L. P.Z. and S.X.; Writing ? Original Draft, J.D. B.L. N.V.M. and G.C.H.; Writing ? Review & Editing, J.D. B.L. N.V.M. and G.C.H.; Supervision, N.V.M. and G.C.H.; Funding Acquisition, N.V.M. and G.C.H. The authors declare no competing interests.
Publisher Copyright:
© 2019 The Author(s)
PY - 2019/6/18
Y1 - 2019/6/18
N2 - Ectopic expression of transcription factors (TFs) can reprogram cell state. However, because of the large combinatorial space of possible TF cocktails, it remains difficult to identify TFs that reprogram specific cell types. Here, we develop Reprogram-Seq to experimentally screen thousands of TF cocktails for reprogramming performance. Reprogram-Seq leverages organ-specific cell-atlas data with single-cell perturbation and computational analysis to predict, evaluate, and optimize TF combinations that reprogram a cell type of interest. Focusing on the cardiac system, we perform Reprogram-Seq on MEFs using an undirected library of 48 cardiac factors and, separately, a directed library of 10 epicardial-related TFs. We identify a combination of three TFs, which efficiently reprogram MEFs to epicardial-like cells that are transcriptionally, molecularly, morphologically, and functionally similar to primary epicardial cells. Reprogram-Seq holds promise to accelerate the generation of specific cell types for regenerative medicine. Direct reprogramming of a cellular state holds promise for regenerative medicine. Duan et al. present Reprogram-Seq to identify, evaluate, and optimize transcription factor cocktails that drive direct reprogramming of a cell state. They apply Reprogram-Seq to generate epicardial-like cells and show how the approach can be leveraged for rational cellular reprogramming.
AB - Ectopic expression of transcription factors (TFs) can reprogram cell state. However, because of the large combinatorial space of possible TF cocktails, it remains difficult to identify TFs that reprogram specific cell types. Here, we develop Reprogram-Seq to experimentally screen thousands of TF cocktails for reprogramming performance. Reprogram-Seq leverages organ-specific cell-atlas data with single-cell perturbation and computational analysis to predict, evaluate, and optimize TF combinations that reprogram a cell type of interest. Focusing on the cardiac system, we perform Reprogram-Seq on MEFs using an undirected library of 48 cardiac factors and, separately, a directed library of 10 epicardial-related TFs. We identify a combination of three TFs, which efficiently reprogram MEFs to epicardial-like cells that are transcriptionally, molecularly, morphologically, and functionally similar to primary epicardial cells. Reprogram-Seq holds promise to accelerate the generation of specific cell types for regenerative medicine. Direct reprogramming of a cellular state holds promise for regenerative medicine. Duan et al. present Reprogram-Seq to identify, evaluate, and optimize transcription factor cocktails that drive direct reprogramming of a cell state. They apply Reprogram-Seq to generate epicardial-like cells and show how the approach can be leveraged for rational cellular reprogramming.
KW - cardiac
KW - cellular reprogramming
KW - single-cell RNA-Seq
KW - single-cell perturbation
KW - transcription factor
UR - http://www.scopus.com/inward/record.url?scp=85066976342&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066976342&partnerID=8YFLogxK
U2 - 10.1016/j.celrep.2019.05.079
DO - 10.1016/j.celrep.2019.05.079
M3 - Article
C2 - 31216470
AN - SCOPUS:85066976342
SN - 2211-1247
VL - 27
SP - 3486-3499.e6
JO - Cell Reports
JF - Cell Reports
IS - 12
ER -